Biopsy Devices Market by Product Type (Biopsy Guns, Biopsy Guidance System, Biopsy Needles (Vacuum Assisted, Fine Needle, Core Needle), Biopsy Forceps, Others) By Guidance Technique, By, Application by End User and Region – Partner & Customer Ecosystem (Product Services, Proposition & Key Features) Competitive Index & Regional Footprints by MarketDigits. - Forecast 2024-2032

Industry : Healthcare | Pages : 167 Pages | Published On : Mar 2024

The Biopsy Device Market is Valued USD 6.54 billion in 2024 and projected to reach USD 21.6 billion by 2032, growing at a CAGR of 14.20% During the Forecast period of 2024-2032.

Biopsy Device Market Size

Market Size ValueUSD 6.54 billion in 2024
Market Size ValueUSD 21.6 billion by 2032
Forecast Period2024-2032
Base Year 2023
Historic Data2020
Forecast UnitsValue (USD Million/USD Billion)
Segments CoveredProduct Type, Guidance Technique, Application and Region
Geographics CoveredNorth America, Latin America, Europe, Asia-Pacific, Middle East & Africa

Major vendors in the global Biopsy Devices market are Argon Medical Devices Boston Scientific Corporation, Becton, B. Braun Melsungen AG , Cardinal Health Inc., CONMED Corporation, Cook Medical, Danaher Corporation, Devicor Medical Products Inc., DTR Medical, Gallini Srl Hologic, Inc., INRAD, Inc., Medtronic plc , Olympus Corporation, Stryker Corporation, TransMed7, LLC and Others.

Market Overview

The global Biopsy Devices market has emerged as a key factor in revolutionizing various industries by offering innovative solutions to long-standing challenges. Biopsy Devices are the medical instruments which are used for collecting the tissue samples from a body for the diagnostic purpose. The biopsy are performed to determine the abnormality in the cells and tissues and helps in the diagnosis of different medical conditions including cancer.

The Biopsy devices have several advantages majorly in the diagnostic purposes including the availability of the actual tissue samples which allows a detailed analysis and diagnostic when compared to normal imaging techniques. This becomes essential in identifying the actual nature of a lesion, tumor or the abnormality.  The increasing geriatric population globally has resulted in the increase demand for the diagnostic procedures including biopsies and the routine screening of the cancer and other diseases which has resulted in the early diagnosis of the devices thus leading to better treatment outcomes.

The rising demand in the liquid biopsy a noninvasive technique is gradually gaining traction. Moreover the liquid biopsy provides a better alternative when compared to traditional tissue biopsies has contributed towards the rising use of the biopsy devices. Also the biopsy devices has its implementation as wekk sucg as infectious diseases and autoimmune disorders thus expanding its scope for the biopsy devices market.

The integration of AI in the healthcare is transforming its various aspects in field of medical diagnostics. With reference to the biopsy devices, AI can assist in image analysis, data interpretation, and decision-making, enhancing the efficiency and accuracy of biopsy procedures. The integration of the AI algos assist in the analysis of medical imaging data from MRIs and CT Scans. This leads to accurate analysis of the target tissues thus reducing the chances of sampling errors.

Market Dynamics


  • Rise in the number of cancer cases.
  • Minimal invasive procedures
  • Early detection and accurate diagnosis of the diseases.
  • Increase in the healthcare expenditures
  • Technical advancements and easy access to the healthcare facilities


  • Advancements in the biopsy devices for the infectious disease diagnostics such as the remote biopsy procedures.
  • Integration with the 3D printing technologies for creating a patient specific biopsy devices.
  • Targeted therapies and the biomarker identification.
  • Implementation of remote biopsy procedures
  • Growing popularity of point of care biopsy devices

Rising Demand for Biopsy Devices in Breast Biopsy Applications

Based on the application the market is segmented into Breast Biopsy, Prostatic Biopsy, Liver Biopsy, Lung Biopsy, Gynaecological Biopsy, Others. The increasing adoption of Biopsy Devices in Breast Biopsy applications is a significant driver which contributes towards the growth of the segment. The most prominent use of the breast biopsy devices is the collection of tissue samples from the identified breast lesion. This collected tissue helps pathologists analyze the cells for signs of malignancy or other abnormalities. Additionally with the integration of AI powered devices it is able to provide the real time guidance during the biopsy devices procedures. This leads to the automated needle tracking and its adjustments which is done on the basis of continuous analysis of the imaging data. The feedback improves the accuracy of the needle placements particularly in difficult to reach anatomical locations.

Also with the integration of AI it can assist pathologist in analyzing the biopsy samples more effectively. Tools such as automated image recognition and analysis can help in identifying specific cellular and molecular characteristics thus increasing the diagnostic process which allows faster and accurate interpretation of the results. Additionally AI driven diagnostics can be easily integrated with EHRs thus ensuring the information is available immediately.

North America dominates the market for Biopsy Devices.

North America dominates the global Biopsy Devices market specifically United States, emerging as the dominating region in the market. The region's dominance can be attributed to the presence of key market players, robust research and development activities, and favorable regulatory frameworks that encourage the testing and deployment of Biopsy Devices technologies. Moreover the increasing aging population and the steep rise in the heart ailment has contributed towards the wider growth and implementation of the biopsy devices. U.S dominates the North American region followed by Canada.

Europe, exhibits high growth potential in the Biopsy Devices market due to alarming increase of cancer cases in the region. The rapid pace of the development of the health infrastructure in the European countries along with the increased cancer cases have led to the growth of the market in the region. The region has the highest cases of cancer globally. As per the stats by World Cancer Research Fund International the highest cancer rate for men and women combined was in Denmark at 334.9 people per 100,000. Additionally The age-standardised rate was at least 300 per 100,000 for 10 countries: Denmark, Ireland, Belgium, Hungary, France, The Netherlands, Australia, Norway, France (New Caledonia) and Slovenia.

Major Segmentations Are Distributed as follows:

  • By Product Type
    • Biopsy Guns
    • Biopsy Guidance System
    • Biopsy Needles
      • Vacuum Assisted
      • Fine Needle
      • Core Needle
    • Biopsy Forceps
    • Others
  • By Guidance Technique
    • Ultrasound
    • Stereotactic Guided
    • MRI Guided
    • CT Guided
    • Others
  • By Application
    • Breast Biopsy
    • Prostatic Biopsy
    • Liver Biopsy
    • Lung Biopsy
    • Gynaecological Biopsy
    • Others
  • By End User
    • Hospitals & Clinics
    • Diagnostic & Imaging
    • Academic & Research Institute
    • Others
  • By Region
    • North America
      • US
      • Canada
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
      • Chile
      • Peru
      • Rest of Latin America
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Russia
      • BENELUX
      • CIS & Russia
      • Nordics
      • Austria
      • Poland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • India
      • South Korea
      • Thailand
      • Indonesia
      • Malaysia
      • Vietnam
      • Australia & New Zealand
      • Rest of Asia Pacific
    • Middle East & Africa
      • Saudi Arabia
      • UAE
      • South Africa
      • Nigeria
      • Egypt
      • Israel
      • Turkey
      • Rest of Middle East & Africa

Recent Developments

  • August 2022, TransMed7, LLC Announces First Clinical Use of Heron Soft Tissue Biopsy Devices for Commercial Launch.

Biopsy Devices Market Report Gives Answers to Following Key Questions:

  • What will be the Biopsy Devices Market’s Trends & growth rate? What analysis has been done of the prices, sales, and volume of the top producers of Biopsy Devices Market?
  • What are the main forces behind the worldwide Biopsy Devices Market? Which companies dominate the Biopsy Devices Market?
  • Which companies dominate the Biopsy Devices Market? Which business possibilities, dangers, and tactics did they embrace in the market?
  • What are the global Biopsy Devices Education's suppliers' opportunities and dangers in Biopsy Devices Market?
  • What is the Biopsy Devices Education's regional sales, income, and pricing analysis? In the Biopsy Devices Market, who are the distributors, traders, and resellers?
  • What are the main geographic areas for various trades that are anticipated to have astounding expansion over the Biopsy Devices Market?
  • What are the main geographical areas for various industries that are anticipated to observe an astounding expansion in Biopsy Devices Market?
  • What are the dominant revenue-generating regions for Biopsy Devices Market, as well as regional growth trends?
  • By the end of the forecast period, what will the market size and growth rate be?
  • What are the main Biopsy Devices Market trends that are influencing the market's expansion?
  • Which key product categories dominate the Biopsy Devices Market? What are the Biopsy Devices Market’s main applications?
  • In the coming years, which Biopsy Devices Market technology will dominate the market?

Reason to purchase this Biopsy Devices Market Report:

  • Determine prospective investment areas based on a detailed trend analysis of the global Biopsy Devices Market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different Biopsy Devices Market segments in the top spending countries across the world and identify the opportunities each offers.
  • Strengthen your understanding of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels that are driving the global Biopsy Devices Market , providing a clear picture of future opportunities that can be tapped, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs that are being undertaken by the different countries within the global Biopsy Devices Market.
  • Make correct business decisions based on a thorough analysis of the total competitive landscape of the sector with detailed profiles of the top Biopsy Devices Market  providers worldwide, including information about their products, alliances, recent contract wins, and financial analysis wherever available.



Table and Figures


At MarketDigits, we take immense pride in our 360° Research Methodology, which serves as the cornerstone of our research process. It represents a rigorous and comprehensive approach that goes beyond traditional methods to provide a holistic understanding of industry dynamics.

This methodology is built upon the integration of all seven research methodologies developed by MarketDigits, a renowned global research and consulting firm. By leveraging the collective strength of these methodologies, we are able to deliver a 360° view of the challenges, trends, and issues impacting your industry.

The first step of our 360° Research Methodology™ involves conducting extensive primary research, which involves gathering first-hand information through interviews, surveys, and interactions with industry experts, key stakeholders, and market participants. This approach enables us to gather valuable insights and perspectives directly from the source.

Secondary research is another crucial component of our methodology. It involves a deep dive into various data sources, including industry reports, market databases, scholarly articles, and regulatory documents. This helps us gather a wide range of information, validate findings, and provide a comprehensive understanding of the industry landscape.

Furthermore, our methodology incorporates technology-based research techniques, such as data mining, text analytics, and predictive modelling, to uncover hidden patterns, correlations, and trends within the data. This data-driven approach enhances the accuracy and reliability of our analysis, enabling us to make informed and actionable recommendations.

In addition, our analysts bring their industry expertise and domain knowledge to bear on the research process. Their deep understanding of market dynamics, emerging trends, and future prospects allows for insightful interpretation of the data and identification of strategic opportunities.

To ensure the highest level of quality and reliability, our research process undergoes rigorous validation and verification. This includes cross-referencing and triangulation of data from multiple sources, as well as peer reviews and expert consultations.

The result of our 360° Research Methodology is a comprehensive and robust research report that empowers you to make well-informed business decisions. It provides a panoramic view of the industry landscape, helping you navigate challenges, seize opportunities, and stay ahead of the competition.

In summary, our 360° Research Methodology is designed to provide you with a deep understanding of your industry by integrating various research techniques, industry expertise, and data-driven analysis. It ensures that every business decision you make is based on a well-triangulated and comprehensive research experience.

Biopsy Device Market
Customize your Report
• Tailored advice to Drive your Performance
• Product Planning Strategy
• New Product Stratergy
• Expanded Research Scope
• Comprehensive Research
• Strategic Consulting
• Provocative and pragmatic
• Accelerate Revenue & Growth
• Evaluate the competitive landscape
• Optimize your partner network
• Analyzing industries
• Mapping trends
• Strategizing growth
• Implementing plans
A comprehensive cogent custom study with Analyzing Industries, Mapping Trends, Straterging growth & Implementing Plans. An in-depth and breadth of composite research, which gives complete support of the generation and evaluation of growth opportunities, and best practices recognition to help increase the revenue. Request a Custom Research below.
Request Customization

Covered Key Topics

Growth Opportunities

Market Growth Drivers

Leading Market Players

Company Market Share

Market Size and Growth Rate

Market Trend and Technological

Research Assistance

We will be happy to help you find what you need. Please call us or write to us:

+1 510-730-3200 (USA Number)